Showing results (171-180 of 232) with videos related to

Sort By:
Pageof 24
American Heart Journal|May 22, 2012
Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery diseaseSvati H Shah, Jie-Lena Sun, Robert D Stevens, et al.
Quality & Safety in Health Care|August 13, 2010
Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curveJ M Taekman, M Stafford-Smith, E J Velazquez, et al.
Open Heart|May 11, 2023
Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registryPatricia Apenteng, Saverio Virdone, John Camm, et al.
The American Journal of Cardiology|September 20, 2018
Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry)Munveer Thind, DaJuanicia N Holmes, Marwan Badri, et al.
American Heart Journal|February 16, 2018
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trialMatthew W Sherwood, Renato D Lopes, Jie Lena Sun, et al.
The American Journal of Medicine|September 13, 2023
Outcomes of Oral Anticoagulation in Atrial Fibrillation Patients With or Without Comorbid Vascular Disease: Insights From the GARFIELD-AF RegistryFreek W A Verheugt, Keith A A Fox, Saverio Virdone, et al.
Circulation. Cardiovascular Quality and Outcomes|February 10, 2011
The impact of postrandomization crossover of therapy in acute coronary syndromes careKenneth W Mahaffey, Karen S Pieper, Yuliya Lokhnygina, et al.
American Heart Journal|December 18, 2002
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B)Debabrata Mukherjee, Kenneth W Mahaffey, David J Moliterno, et al.
Circulation|January 21, 2012
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trialShaun G Goodman, Robert Clare, Karen S Pieper, et al.
Circulation|September 7, 2000
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial InvestigatorsM T Roe, R A Harrington, D M Prosper, et al.
Pageof 24